• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CD90表达在癌症患者中的预后及临床病理价值：一项系统评价与荟萃分析

Prognostic and clinicopathological value of CD90 expression in cancer patients: a systematic review and meta-analysis.

作者信息

Koh Hyun Min, Lee Hyun Ju, Kim Dong Chul

机构信息

Department of Pathology, Gyeongsang National University Changwon Hospital, Changwon, Korea.

Department of Pathology, Soonchunhyang University College of Medicine, Cheonan, Korea.

出版信息

Transl Cancer Res. 2021 Jul;10(7):3356-3363. doi: 10.21037/tcr-21-266.

DOI:10.21037/tcr-21-266
PMID:35116641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8798514/
Abstract

BACKGROUND

Recent studies have shown that CD90 has an important role in cancer development. Moreover, CD90 is reportedly associated with cancer progression, metastasis, and poor prognosis. Thus, we performed this meta-analysis to investigate the prognostic and clinicopathological value of CD90 expression in patients with cancer.

METHODS

Eligible studies were collected by searching PubMed, Embase, and the Cochrane library. The pooled results were analyzed to reveal the association between CD90 expression and survival as well as the clinicopathological characteristics of cancer patients.

RESULTS

CD90 overexpression was associated with poor survival in cancer patients [for overall survival, hazard ratio (HR): 2.56, 95% confidence interval (CI): 1.42-4.62, P=0.002; for disease-free survival, HR: 1.88, 95% CI: 1.08-3.27, P=0.025] and was also significantly correlated with a larger tumor size [odds ratio (OR): 1.97, 95% CI: 1.01-3.85, P=0.048), higher tumor grade (OR: 2.72, 95% CI: 1.33-5.54, P=0.006), lymph node metastasis (OR: 3.66, 95% CI: 1.14-11.78, P=0.029), and higher tumor-node-metastasis stage (OR: 4.79, 95% CI: 2.28-10.04, P<0.001).

CONCLUSIONS

CD90 overexpression could predict poor prognosis and may hence be a potential prognostic biomarker for cancer patients.

摘要

背景

近期研究表明，CD90在癌症发展过程中发挥着重要作用。此外，据报道CD90与癌症进展、转移及不良预后相关。因此，我们开展了这项荟萃分析，以探究CD90表达在癌症患者中的预后及临床病理价值。

方法

通过检索PubMed、Embase和Cochrane图书馆收集符合条件的研究。对汇总结果进行分析，以揭示CD90表达与生存率之间的关联以及癌症患者的临床病理特征。

结果

CD90过表达与癌症患者的不良生存相关[总生存期，风险比（HR）：2.56，95%置信区间（CI）：1.42 - 4.62，P = 0.002；无病生存期，HR：1.88，95% CI：1.08 - 3.27，P = 0.025]，并且还与更大的肿瘤大小[比值比（OR）：1.97，95% CI：1.01 - 3.85，P = 0.048]、更高的肿瘤分级（OR：2.72，95% CI：1.33 - 5.54，P = 0.006）、淋巴结转移（OR：3.66，95% CI：1.14 - 11.78，P = 0.029）以及更高的肿瘤-淋巴结-转移分期（OR：4.79，95% CI：2.28 - 10.04，P < 0.001）显著相关。

结论

CD90过表达可预测不良预后，因此可能是癌症患者潜在的预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecd2/8798514/d693bb3c2a3b/tcr-10-07-3356-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecd2/8798514/ee190a8aeac2/tcr-10-07-3356-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecd2/8798514/3e74467f3058/tcr-10-07-3356-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecd2/8798514/34ca1622f851/tcr-10-07-3356-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecd2/8798514/1a3a363894ad/tcr-10-07-3356-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecd2/8798514/a4812bfa23c5/tcr-10-07-3356-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecd2/8798514/d693bb3c2a3b/tcr-10-07-3356-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecd2/8798514/ee190a8aeac2/tcr-10-07-3356-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecd2/8798514/3e74467f3058/tcr-10-07-3356-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecd2/8798514/34ca1622f851/tcr-10-07-3356-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecd2/8798514/1a3a363894ad/tcr-10-07-3356-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecd2/8798514/a4812bfa23c5/tcr-10-07-3356-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecd2/8798514/d693bb3c2a3b/tcr-10-07-3356-f6.jpg

相似文献

1
Prognostic and clinicopathological value of CD90 expression in cancer patients: a systematic review and meta-analysis.CD90表达在癌症患者中的预后及临床病理价值：一项系统评价与荟萃分析
Transl Cancer Res. 2021 Jul;10(7):3356-3363. doi: 10.21037/tcr-21-266.
2
Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.mTOR和磷酸化mTOR表达在食管鳞状细胞癌患者中的临床病理及预后意义：一项系统评价和荟萃分析
BMC Cancer. 2016 Nov 11;16(1):877. doi: 10.1186/s12885-016-2940-7.
3
Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.长链非编码 RNA SNHG16 在人类癌症中的表达的临床病理意义和预后：一项荟萃分析。
BMC Cancer. 2020 Jul 16;20(1):662. doi: 10.1186/s12885-020-07149-w.
4
Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysis.巢蛋白表达在乳腺癌患者中的临床病理及预后意义：一项系统评价与Meta分析
Cancer Cell Int. 2020 May 14;20:169. doi: 10.1186/s12935-020-01252-5. eCollection 2020.
5
Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.S100A4 表达在非小细胞肺癌中的临床病理和预后价值：一项荟萃分析。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20201710.
6
Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis.p-stat3在胃癌患者中的预后价值及临床病理意义：一项系统评价与Meta分析
Medicine (Baltimore). 2016 Feb;95(5):e2641. doi: 10.1097/MD.0000000000002641.
7
Prognostic and clinicopathological significance of SNHG20 in human cancers: a meta-analysis.SNHG20在人类癌症中的预后及临床病理意义：一项荟萃分析
Cancer Cell Int. 2020 Jul 11;20:304. doi: 10.1186/s12935-020-01403-8. eCollection 2020.
8
Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.缺氧诱导因子-1α 在乳腺癌中的临床病理和预后价值：包含 5177 名患者的荟萃分析。
Clin Transl Oncol. 2020 Oct;22(10):1892-1906. doi: 10.1007/s12094-020-02332-8. Epub 2020 Mar 12.
9
Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis.癌中Gankyrin过表达的预后及临床病理意义：一项荟萃分析的证据
Onco Targets Ther. 2016 Apr 4;9:1961-8. doi: 10.2147/OTT.S101687. eCollection 2016.
10
Prognostic and Clinicopathological Value of Rac1 in Cancer Survival: Evidence from a Meta-Analysis.Rac1在癌症生存中的预后及临床病理价值：一项荟萃分析的证据
J Cancer. 2018 Jun 23;9(14):2571-2579. doi: 10.7150/jca.24824. eCollection 2018.

引用本文的文献

1
Analysis of Cancer Stem Cell Markers in Various Histological Subtypes of Adrenocortical Cancer.肾上腺皮质癌不同组织学亚型中癌症干细胞标志物的分析
Curr Issues Mol Biol. 2024 Dec 5;46(12):13798-13810. doi: 10.3390/cimb46120825.
2
Significance of CD70, VEGF, and CD90 Immunohistochemical Expression in Colorectal Cancer.CD70、VEGF 和 CD90 免疫组织化学表达在结直肠癌中的意义。
Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3691-3699. doi: 10.31557/APJCP.2024.25.10.3691.

本文引用的文献

1
CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis.CD90 在人肝内胆管癌中的表达与淋巴结转移和预后不良相关。
J Surg Oncol. 2018 Sep;118(4):664-674. doi: 10.1002/jso.25192. Epub 2018 Sep 9.
2
High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors.高 CD90（THY-1）表达与基底样乳腺癌肿瘤的细胞转化和预后不良呈正相关。
PLoS One. 2018 Jun 27;13(6):e0199254. doi: 10.1371/journal.pone.0199254. eCollection 2018.
3
Biomarker for Cancer: A great Promise for Future.
癌症生物标志物：未来的巨大希望。
World J Oncol. 2011 Aug;2(4):151-157. doi: 10.4021/wjon352w. Epub 2011 Aug 24.
4
Overexpression of Thy1 and ITGA6 is associated with invasion, metastasis and poor prognosis in human gallbladder carcinoma.Thy1和ITGA6的过表达与人类胆囊癌的侵袭、转移及不良预后相关。
Oncol Lett. 2016 Dec;12(6):5136-5144. doi: 10.3892/ol.2016.5341. Epub 2016 Nov 2.
5
Multiple roles of CD90 in cancer.CD90在癌症中的多种作用。
Tumour Biol. 2016 Sep;37(9):11611-11622. doi: 10.1007/s13277-016-5112-0. Epub 2016 Jun 23.
6
The clinical pathological significance of Thy1 and CD49f expression in chondrosarcomas.Thy1和CD49f在软骨肉瘤中的表达的临床病理意义
Pathol Res Pract. 2016 Jul;212(7):636-42. doi: 10.1016/j.prp.2016.04.006. Epub 2016 Apr 22.
7
The prognostic value of combination of CD90 and OCT4 for hepatocellular carcinoma after curative resection.CD90 和 OCT4 联合对肝癌根治性切除术后的预后价值。
Neoplasma. 2016;63(2):288-98. doi: 10.4149/neo_2016_036.
8
Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma.癌症干细胞标志物与肝细胞癌的早期复发和生存相关。
World J Gastroenterol. 2014 Feb 28;20(8):2098-106. doi: 10.3748/wjg.v20.i8.2098.
9
Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis.Thy1/CD90 在人肝癌中的过表达与 HBV 感染和不良预后相关。
Acta Histochem. 2011 Dec;113(8):833-8. doi: 10.1016/j.acthis.2011.01.001. Epub 2011 Jan 26.
10
Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses.Thy-1，一种影响细胞黏附、增殖、存活及细胞因子/生长因子反应的信号传导多功能调节剂。
Biochim Biophys Acta. 2006 Oct;1763(10):991-9. doi: 10.1016/j.bbamcr.2006.08.008. Epub 2006 Aug 18.